Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Roche's Targeted Sequencing Panels

Premium

Roche has launched a series of new SeqCap EZ targeted sequencing panels. SeqCap EZ Exome Plus Library enables researchers to custom design an exome kit by including an additional 50 megabases of custom targets with the existing 64-megabase exome kit. SeqCap EZ Exome +UTR Library adds 32 megabases of untranslated regions to the 64-megabase exome kit.

Additionally, the company has launched several disease-specific panels, including SeqCap EZ Comprehensive Cancer, which covers 578 cancer genes, and SeqCap EZ Neurology Panel, which covers 256 genes associated with 87 neurological disorders, including Parkinson's and Alzheimer's disease, epilepsy, and autism.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more